Laura Hagerty, PhD

Dr. Hagerty has spent more than a decade pursuing therapies for muscular dystrophy. She began her career in drug development as a preclinical pharmacologist with Acceleron Pharma and later with the Skeletal Muscle Metabolism Discovery Unit at GlaxoSmithKline. Prior to joining